Clinical trial
A Phase 1 Study of SRF617 in Patients With Advanced Solid Tumors
NCT04336098 is registered in ClinicalTrials.gov with Coherus Oncology, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of SRF617 in Patients With Advanced Solid Tumors
- Lead sponsor
- Coherus Oncology, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 16, 2020
- Completion date
- August 25, 2023
- Enrollment
- 85 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
advanced solid tumor